Key result
Rhythm control in AF fails to reduce major events, leaving symptom relief the primary indication.
Why the study?
Does ablation improve outcomes compared to drugs as first-line therapy in patients with paroxysmal atrial fibrillation?
Population
Patients with paroxysmal atrial fibrillation
Comparison
Ablation vs Antiarrhythmic drugs
Design
Review
Authors
Loading...
AF mortality risk persists with AADs; leaves open whether refined risk scores improve outcomes or guide therapy in observational cohorts.
Does ablation improve outcomes compared to drugs as first-line therapy in patients with paroxysmal atrial fibrillation?
Rhythm control strategies in atrial fibrillation are primarily indicated for symptom and quality of life improvement rather than mortality or stroke reduction.
Hanley et al. (2014) conducted a review in Paroxysmal Atrial Fibrillation. Ablation vs. Antiarrhythmic drugs was evaluated. Rhythm control strategies in atrial fibrillation have not been shown to reduce mortality, stroke, or heart failure, making symptom improvement the primary indication for pursuing sinus rhythm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: